Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kanami Sugimoto"'
Autor:
Hidetoshi Shimizu, Michael A. Tortorici, Yoshiyasu Ohta, Kei Ogawa, Sheikh Mohammed Ashfaq Rahman, Aya Fujii, Yuki Hiraga, Mizue Kawai, Kanami Sugimoto‐Kawabata, Mattheus (Thijs) vanIersel, Jan Jaap vanLier, Stephen Djedjos, B. T. Slingsby, David M. Rodman
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 8, Pp n/a-n/a (2024)
Abstract Dysregulation of the mineralocorticoid hormone aldosterone is an increasingly prevalent cause of hypertension. Aldosterone synthase (CYP11B2) shares 93% homology to 11β‐hydroxylase (CYP11B1), which produces cortisol. Lorundrostat, a highl
Externí odkaz:
https://doaj.org/article/c92800d2ef6c453baa9149dda089faef
Autor:
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
Publikováno v:
Intestinal Research, Vol 20, Iss 3, Pp 329-341 (2022)
Background/Aims Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiated to evaluate its safety and effectiveness in pa
Externí odkaz:
https://doaj.org/article/71e114b21acf4f648efaa0b86a6ec480
Autor:
Shiro Nakamura, Teita Asano, Yoshihito Tanaka, Kanami Sugimoto, Shinichi Yoshigoe, Yasuo Suzuki
Publikováno v:
Inflammatory Intestinal Diseases (2022)
Introduction: Real-world evidence for the effectiveness and safety of golimumab (GLM) in patients with ulcerative colitis (UC) is limited. The aim of this study was to investigate the 52-week effectiveness and safety of GLM treatment for UC. Methods:
Externí odkaz:
https://doaj.org/article/41b73e39759c4bd9b4f987ad46c0f1e2
Autor:
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Lars Verschuren, Robert Kleemann, Kozo Oka
Publikováno v:
Biology Open, Vol 8, Iss 5 (2019)
Non-alcoholic steatohepatitis (NASH) is a fast-growing liver disease in the Western world. Currently, only a few animal models show both the metabolic and histological features of human NASH. We aimed to explore murine NASH models in a time dependent
Externí odkaz:
https://doaj.org/article/37f78b7dfb294aa496b0adfa15c71599
Autor:
Kanami Sugimoto-Kawabata, Hiroshi Shimada, Kaoru Sakai, Kazuo Suzuki, Thomas Kelder, Elsbet J. Pieterman, Louis H. Cohen, Louis M. Havekes, Hans M. Princen, Anita M. van den Hoek
Publikováno v:
Journal of Lipid Research, Vol 54, Iss 5, Pp 1255-1264 (2013)
Bile acid sequestrants (BASs) are cholesterol-lowering drugs that also affect hyperglycemia. The mechanism by which BASs exert these and other metabolic effects beyond cholesterol lowering remains poorly understood. The present study aimed to investi
Externí odkaz:
https://doaj.org/article/aef6254d56e24440b004893f7a2d5f51
Autor:
Aya Fujii, Yuki Hiraga, Mizue Kawai, Kei Ogawa, Yoshiyasu Ohta, Sheikh Mohammed Ashfaq Rahman, Hidetoshi Shimizu, Kanami Sugimoto-Kawabata, Mattheus (Thijs) Van Iersel, Jan Jaap Van Lier, BT Slingsby, David Rodman
Publikováno v:
Journal of the American College of Cardiology. 81:616
Publikováno v:
Journal of Sports Sciences. 38:6-12
This study aimed to examine the characteristics of electromyography (EMG) and kinematics of the supporting leg affecting energy cost while running at incline, level, and decline slopes. Twelve male Japanese middle- and long-distance runners volunteer
Autor:
Sayuka Kato, Naomichi Abe, Ryuta Saito, Kozo Oka, Takuma Tsuchida, Lars Verschuren, Robert Kleemann, Kanami Sugimoto
Publikováno v:
Biology Open, Vol 8, Iss 5 (2019)
Biology Open
Biology Open
Non-alcoholic steatohepatitis (NASH) is a fast-growing liver disease in the Western world. Currently, only a few animal models show both the metabolic and histological features of human NASH. We aimed to explore murine NASH models in a time dependent
Publikováno v:
The Proceedings of the Annual Convention of the Japanese Psychological Association. 84:PO-056
Autor:
Kanami, Sugimoto
Publikováno v:
Folia Pharmacologica Japonica. 144:64-68